Literature DB >> 11734436

Hyaluronic acid blocks porcine pancreatic elastase (PPE)-induced bronchoconstriction in sheep.

M Scuri1, W M Abraham, Y Botvinnikova, R Forteza.   

Abstract

We previously showed that inhaled porcine pancreatic elastase (PPE) causes bronchoconstriction in sheep via a bradykinin-mediated mechanism. Hyaluronic acid (HA), in vitro, binds and inactivates airway tissue kallikrein (TK), the enzyme responsible for kinin generation. Therefore, we hypothesized that in vivo, HA should prevent PPE-induced bronchoconstriction by binding and inactivating TK. To test this, we measured pulmonary resistance (RL) in allergic sheep before and after inhalation of PPE alone (500 microg) and after pretreatment with either inhaled HA at 70 kD, designated low molecular weight (LMW)-HA or 200 kD, designated high molecular weight (HMW)-HA at different concentrations. Inhaled PPE increased RL 147 +/- 8% over baseline values and this effect was associated with a 111 +/- 28% increase in bronchoalveolar lavage fluid (BALF) TK activity. HA blocked the PPE-induced bronchoconstriction and the increase in BALF TK activity in a dose- dependent and molecular weight-dependent fashion. HA alone had no effect on RL. Instillation of PPE in the lung increased kinin concentrations in BALF, a result consistent with the PPE-induced increase in BALF TK activity. Our findings show that HA blocks PPE-induced bronchoconstriction in a dose-dependent and molecular weight-dependent fashion by a mechanism that may, in part, be related to inhibition of TK activity and the formation of kinins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734436     DOI: 10.1164/ajrccm.164.10.2011115

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

1.  Leukocytic cell sources of airway tissue kallikrein.

Authors:  Isabel T Lauredo; Rosanna M Forteza; Yelena Botvinnikova; William M Abraham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12-05       Impact factor: 5.464

Review 2.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

Review 3.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

4.  Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice.

Authors:  Stavros Garantziotis; Zhuowei Li; Erin N Potts; Koji Kimata; Lisheng Zhuo; Daniel L Morgan; Rashmin C Savani; Paul W Noble; W Michael Foster; David A Schwartz; John W Hollingsworth
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

Review 5.  Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease.

Authors:  Alba B Souza-Fernandes; Paolo Pelosi; Patricia R M Rocco
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 6.  Hyaluronan - a functional and structural sweet spot in the tissue microenvironment.

Authors:  James Monslow; Priya Govindaraju; Ellen Puré
Journal:  Front Immunol       Date:  2015-05-15       Impact factor: 7.561

Review 7.  Potential therapeutic applications of hyaluronan in the lung.

Authors:  Jerome O Cantor
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

8.  High-molecular-weight hyaluronan--a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats.

Authors:  Yung-Yang Liu; Cheng-Hung Lee; Rejmon Dedaj; Hang Zhao; Hicham Mrabat; Aviva Sheidlin; Olga Syrkina; Pei-Ming Huang; Hari G Garg; Charles A Hales; Deborah A Quinn
Journal:  Crit Care       Date:  2008-08-08       Impact factor: 9.097

Review 9.  The Rise and Fall of Hyaluronan in Respiratory Diseases.

Authors:  Mark E Lauer; Raed A Dweik; Stavros Garantziotis; Mark A Aronica
Journal:  Int J Cell Biol       Date:  2015-09-10

Review 10.  Use of Hyaluronic Acid (HA) in Chronic Airway Diseases.

Authors:  Luis Máiz Carro; Miguel A Martínez-García
Journal:  Cells       Date:  2020-09-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.